Levetiracetam versus phenytoin for second-line treatment of convulsive status epilepticus in children (ConSEPT): an open-label, multicentre, randomised controlled trial-Reference-Cited by-同舟云学术

Levetiracetam versus phenytoin for second-line treatment of convulsive status epilepticus in children (ConSEPT): an open-label, multicentre, randomised controlled trial

Published:2019-05 Issue:10186 Volume:393 Page:2135-2145
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Dalziel Stuart R,Borland Meredith L,Furyk Jeremy,Bonisch Megan,Neutze Jocelyn,Donath Susan,Francis Kate L,Sharpe Cynthia,Harvey A Simon,Davidson Andrew,Craig Simon,Phillips Natalie,George Shane,Rao Arjun,Cheng Nicholas,Zhang Michael,Kochar Amit,Brabyn Christine,Oakley Ed,Babl Franz E

Publisher

Elsevier BV

Subject

General Medicine

Reference31 articles.

1. Outcome of convulsive status epilepticus: a review;Novorol;Arch Dis Child,2007

2. Incidence, cause, and short-term outcome of convulsive status epilepticus in childhood: prospective population-based study;Chin;Lancet,2006

3. Outcome of paediatric convulsive status epilepticus: a systematic review;Raspall-Chaure;Lancet Neurol,2006

4. Advanced paediatric life support: a practical approach to emergencies,2016

5. Epilepsies: diagnosis and management,2012

Cited by 138 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Research Status, Synthesis and Clinical Application of Antiepileptic Drugs;Current Medicinal Chemistry;2024-02

2. Convulsioni e stato di male epilettico: schema sinottico per l'intervento in emergenza/urgenza - Aggiornamento 2023;Medico e Bambino Pagine elettroniche;2023-12-22

3. Management strategies for refractory status epilepticus;Journal of Neurocritical Care;2023-12-19

4. Evaluation of the safety and tolerability of intravenous undiluted levetiracetam at a pediatric institution;Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy;2023-12-16

5. Analysis of Adverse Drug Reactions in Pediatric Patients with Epilepsy: An Intensive Pharmacovigilance Study;Children;2023-11-01